Lifecore Biomedical to Participate in Upcoming Investor Conferences
Lifecore Biomedical (NASDAQ: LFCR) will participate in two investor conferences in November 2025: the Jefferies 2025 Global Healthcare Conference in London and the Stephens Annual Investment Conference in Nashville. Paul Josephs, president and CEO, will deliver a corporate presentation and take part in investor meetings at Jefferies on Nov 18, 2025 at 9:30 a.m. GMT (4:30 a.m. ET) and will be a featured fireside chat speaker at Stephens on Nov 20, 2025 at 9:00 a.m. CT. Management will hold 1-on-1 meetings across both events (Nov 17–20 and Nov 18–20 respectively). Webcasts of both sessions will be available live and as replays via Lifecore’s Investor Events & Presentations page at https://ir.lifecore.com/events-presentations.
Lifecore Biomedical (NASDAQ: LFCR) parteciperà a due conferenze per investitori a novembre 2025: la Jefferies 2025 Global Healthcare Conference a Londra e la Stephens Annual Investment Conference a Nashville. Paul Josephs, presidente e CEO, terrà una presentazione aziendale e parteciperà a incontri con gli investitori a Jefferies il 18 novembre 2025 alle 9:30 GMT (4:30 ET) e sarà uno speaker in un fireside chat in primo piano a Stephens il 20 novembre 2025 alle 9:00 CT. La direzione terrà incontri individuali 1 contro 1 in entrambi gli eventi (dal 17 al 20 novembre e dal 18 al 20 novembre rispettivamente). Le trasmissioni in webcast di entrambe le sessioni saranno disponibili dal vivo e in replica tramite la pagina Lifecore’s Investor Events & Presentations all’indirizzo https://ir.lifecore.com/events-presentations.
Lifecore Biomedical (NASDAQ: LFCR) participará en dos conferencias para inversores en noviembre de 2025: la Jefferies 2025 Global Healthcare Conference en Londres y la Stephens Annual Investment Conference en Nashville. Paul Josephs, presidente y director ejecutivo, presentará una ponencia corporativa y participará en reuniones con inversores en Jefferies el 18 de noviembre de 2025 a las 9:30 a.m. GMT (4:30 a.m. ET) y será un orador destacado en un fireside chat en Stephens el 20 de noviembre de 2025 a las 9:00 a.m. CT. La dirección llevará a cabo reuniones individuales 1 a 1 en ambos eventos (del 17 al 20 de noviembre y del 18 al 20 de noviembre, respectivamente). Las transmisiones en vivo y en repetición de ambas sesiones estarán disponibles a través de la página de Lifecore’s Investor Events & Presentations en https://ir.lifecore.com/events-presentations.
Lifecore Biomedical(NASDAQ: LFCR) 는 2025년 11월 두 건의 투자자 회의에 참여합니다: 런던에서 개최되는 Jefferies 2025 Global Healthcare Conference와 내슈빌에서 열리는 Stephens Annual Investment Conference. 사장 겸 CEO인 Paul Josephs는 기업 프리젠테이션을 진행하고 Jefferies에서 2025년 11월 18일 9:30 GMT (동부표시 4:30)에 투자자 미팅에 참여하며 Stephens에서의 fireside chat 연설자로 2025년 11월 20일 9:00 CT에 발표할 예정입니다. 경영진은 두 행사에서 각각 1대1 미팅을 가질 예정입니다(각각 11월 17–20일, 11월 18–20일). 두 세션의 웹캐스트는 Lifecore의 Investor Events & Presentations 페이지 https://ir.lifecore.com/events-presentations에서 라이브 및 재방송으로 제공됩니다.
Lifecore Biomedical (NASDAQ : LFCR) participera à deux conférences pour investisseurs en novembre 2025 : la Jefferies 2025 Global Healthcare Conference à Londres et la Stephens Annual Investment Conference à Nashville. Paul Josephs, président et CEO, présentera une communication d'entreprise et participera à des réunions avec les investisseurs lors de Jefferies le 18 novembre 2025 à 9h30 GMT (4h30 ET) et sera un intervenant lors d’un fireside chat à Stephens le 20 novembre 2025 à 9h00 CT. La direction organisera des réunions en tête-à-tête lors des deux événements (du 17 au 20 novembre et du 18 au 20 novembre, respectivement). Les diffusions en direct et les rediffusions des deux sessions seront disponibles via la page Lifecore’s Investor Events & Presentations à l’adresse https://ir.lifecore.com/events-presentations.
Lifecore Biomedical (NASDAQ: LFCR) wird im November 2025 an zwei Investorenkonferenzen teilnehmen: der Jefferies 2025 Global Healthcare Conference in London und der Stephens Annual Investment Conference in Nashville. Paul Josephs, Präsident und CEO, hält eine Unternehmenspräsentation und nimmt an Investorenmeetings bei Jefferies am 18. November 2025 um 9:30 Uhr GMT (4:30 Uhr ET) teil und wird als Featured Fireside Chat-Speaker bei Stephens am 20. November 2025 um 9:00 Uhr CT auftreten. Das Management wird 1-zu-1- meetings bei beiden Veranstaltungen abhalten (jeweils vom 17.–20. und 18.–20. November). Die Webcasts beider Sitzungen werden live und als Wiederholungen über Lifecore’s Investor Events & Presentations-Seite unter https://ir.lifecore.com/events-presentations verfügbar sein.
Lifecore Biomedical (ناسداك: LFCR) ستشارك في مؤتمرين للمستثمرين في نوفمبر 2025: Jefferies 2025 Global Healthcare Conference في لندن و Stephens Annual Investment Conference في ناشفيل. سيقدم بول جوسفز، الرئيس والمدير التنفيذي، عرضاً لشركة وسيشارك في اجتماعات المستثمرين في Jefferies في 18 نوفمبر 2025 الساعة 9:30 صباحاً بتوقيت GMT (4:30 صباحاً بتوقيت شرق الولايات المتحدة) وسيكون متحدثاً رئيسياً خلال جلسة fireside chat في Stephens في 20 نوفمبر 2025 الساعة 9:00 صباحاً بتوقيت CT. ستعقد الإدارة اجتماعات فردية 1 إلى 1 في كلا الحدثين (من 17 إلى 20 نوفمبر ومن 18 إلى 20 نوفمبر على التوالي). ستتوفر البثوث عبر الإنترنت لكلا الجلستين مباشرة وبالتعليقات عبر صفحة Lifecore’s Investor Events & Presentations على العنوان https://ir.lifecore.com/events-presentations.
- None.
- None.
CHASKA, Minn, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in two upcoming investor conferences. Details regarding Lifecore’s participation are as follows:
- Jefferies 2025 Global Healthcare Conference – London
Details: Paul Josephs, Lifecore’s president and chief executive officer, will deliver a corporate presentation and Lifecore management will participate in investor meetings
Conference Dates: November 17-20, 2025
Presentation Time/Date: 9:30 – 9:55 a.m. Greenwich Mean Time (4:30 – 4:55 a.m. Eastern Time) on Tuesday, November 18, 2025, webcast available
Location: London, UK
- Stephens Annual Investment Conference
Details: Mr. Josephs will be a featured speaker in a fireside chat and Lifecore management will participate in 1-on-1 meetings
Conference Dates: November 18-20, 2025
Fireside Chat Time/Date: 9:00 – 9:45 a.m. Central Time on Thursday, November 20, 2025, webcast available
Location: Nashville
Webcasts of the Jefferies presentation and the Stephens fireside chat may be accessed via a link on Lifecore’s investor website on the Investor Events & Presentations page at: https://ir.lifecore.com/events-presentations. Additionally, replays of the webcasts will be available on the Lifecore website following the conference.
About Lifecore Biomedical
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.

Lifecore Biomedical, Inc. Contact Information: Vida Strategic Partners Stephanie Diaz (Investors) 415-675-7401 sdiaz@vidasp.com Tim Brons (Media) 415-675-7402 tbrons@vidasp.com Ryan D. Lake (CFO) Lifecore Biomedical 952-368-6244 ryan.lake@lifecore.com